Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Ms. Mary K. MorelandExec. VP of HR | 5.31k | 501.69k | Acquisition Under Employee Benefit Plan | 94.41 | 121.45k | 4.58% |
| 2026-04-27 | Mr. Daniel J. StarksIndependent Director | 10.00k | 926.54k | 買い | 92.65 | 6.73M | 0.15% |
| 2026-04-23 | Mr. Philip P. BoudreauCFO & Exec. VP of Finance | 2.20k | 201.30k | 買い | 91.50 | 82.65k | 2.73% |
| 2026-04-23 | Mr. Philip P. BoudreauCFO & Exec. VP of Finance | 8.91k | 819.98k | Acquisition Under Employee Benefit Plan | 92.04 | 82.65k | 12.08% |
| 2026-03-02 | Mr. Eric ShroffSVP of Rapid & Molecular Diagnostics | -709.00 | 81.95k | 売り | 115.58 | 39.16k | -1.78% |
| 2026-02-27 | Mr. Eric ShroffSVP of Rapid & Molecular Diagnostics | -1.38k | 160.90k | Sale to Issuer | 116.26 | 39.16k | -3.41% |
| 2026-02-27 | Mr. Christopher J. ScogginsExec. VP of Diabetes Care | -5.00k | 580.95k | Sale to Issuer | 116.26 | 77.13k | -6.08% |
| 2026-03-02 | Mr. Daniel Gesua Sive SalvadoriExec. VP and Group President of Established Pharmaceuticals & Nutritional Products | -885.00 | 102.29k | 売り | 115.58 | 146.38k | -0.60% |
| 2026-02-27 | Mr. Daniel Gesua Sive SalvadoriExec. VP and Group President of Established Pharmaceuticals & Nutritional Products | -6.62k | 769.06k | Sale to Issuer | 116.26 | 146.38k | -4.32% |
| 2026-03-02 | Mr. Louis H. MorroneExec. VP of Core Diagnostics | -1.14k | 132.22k | 売り | 115.58 | 76.86k | -1.47% |
| 2026-02-27 | Mr. Louis H. MorroneExec. VP of Core Diagnostics | -4.04k | 469.69k | Sale to Issuer | 116.26 | 76.86k | -4.99% |
| 2026-03-02 | Ms. Mary K. MorelandExec. VP of HR | -613.00 | 70.85k | 売り | 115.58 | 116.14k | -0.53% |
| 2026-02-27 | Ms. Mary K. MorelandExec. VP of HR | -4.63k | 538.28k | Sale to Issuer | 116.26 | 116.14k | -3.83% |
| 2026-03-02 | Mr. John A. McCoyVP of Finance & Controller | -585.00 | 67.61k | 売り | 115.58 | 24.69k | -2.31% |
| 2026-02-27 | Mr. John A. McCoyVP of Finance & Controller | -1.14k | 132.77k | Sale to Issuer | 116.26 | 24.69k | -4.42% |
| 2026-02-27 | Mr. Robert B. FordChairman, President & CEO | -30.31k | 3.52M | Sale to Issuer | 116.26 | 522.66k | -5.48% |
| 2026-02-27 | Ms. Lisa D. EarnhardtExec. VP & Group President of Medical Devices | -8.58k | 997.16k | Sale to Issuer | 116.26 | 90.41k | -8.67% |
| 2026-03-02 | Ms. Elizabeth CushmanExec. VP, General Counsel & Secretary | -263.00 | 30.40k | 売り | 115.58 | 38.57k | -0.68% |
| 2026-02-27 | Ms. Elizabeth CushmanExec. VP, General Counsel & Secretary | -1.42k | 165.21k | Sale to Issuer | 116.26 | 38.57k | -3.55% |
| 2026-02-27 | Mr. Philip P. BoudreauCFO & Exec. VP of Finance | -7.44k | 865.09k | Sale to Issuer | 116.26 | 71.54k | -9.42% |
| 2026-02-04 | Mr. Daniel J. StarksIndependent Director | 10.00k | 1.09M | 買い | 108.33 - 109.14 | 6.72M | 0.15% |
| 2026-01-23 | Mr. Robert B. FordChairman, President & CEO | 18.80k | 2.01M | 買い | 107.13 | 469.51k | 4.17% |
| 2025-12-11 | Mr. Daniel Gesua Sive SalvadoriExec. VP and Group President of Established Pharmaceuticals & Nutritional Products | -1.54k | 189.36k | Other Disposition | 123.28 | 132.23k | -1.15% |
| 2025-11-25 | Mr. Eric ShroffSVP of Rapid & Molecular Diagnostics | -1.59k | 203.04k | 売り | 128.02 | 30.38k | -4.96% |
| 2025-09-01 | Mr. John A. McCoyVP of Finance & Controller | -79.00 | 10.48k | Sale to Issuer | 132.66 | 21.04k | -0.37% |
| 2025-09-01 | Mr. Philip P. BoudreauCFO & Exec. VP of Finance | -387.00 | 51.34k | Sale to Issuer | 132.66 | 50.98k | -0.75% |
| 2025-08-08 | Mr. Philip P. BoudreauCFO & Exec. VP of Finance | -5.55k | 746.76k | 売り | 134.55 | 51.36k | -9.75% |
| 2025-06-30 | Mr. Louis H. MorroneExec. VP of Core Diagnostics | -269.00 | 36.15k | Sale to Issuer | 134.38 | 66.62k | -0.40% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
